Public Calendar: December 20 - 26, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
Event Date: 12/21/2020
Location: Las Vegas, NV
Subject: COVID-19 Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of Governor Steve Sisolak's office and Nevada's public health officials
Event Date: 12/22/2020
Location: Cheyenne, WY
Subject: COVID-19 Efforts
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of Governor Mark Gordon's office and Wyoming's public health officials
Event Date: 12/23/2020
Location: Virtual
Subject: COVID-19 Vaccines
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Janice Mathis, Johnetta Betsch Cole (National Council of Negro Women);
Event Date: 12/23/2020
Location: Virtual
Subject: COVID-19 Vaccines Process
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of United States Pharmacopeia
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
No Significant Event
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 12/21/2020
Location: Virtual
Subject: Food Safety Education
FDA Participant/Group: CONRAD CHOINIERE; NINA ZIMDAHL;
Non FDA Participant/Group: Several members from Disney, the Partnership for Food Safety Education, and the United States Department of Agriculture
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 12/22/2020
Location: Virtual
Subject: CBER 2021 Priorities
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Alliance for a Stronger FDA
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event